173 related articles for article (PubMed ID: 38396845)
1. All Three AKT Isoforms Can Upregulate Oxygen Metabolism and Lactate Production in Human Hepatocellular Carcinoma Cell Lines.
Tian LY; Smit DJ; Popova NV; Horn S; Velasquez LN; Huber S; Jücker M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396845
[TBL] [Abstract][Full Text] [Related]
2. Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells.
Grabinski N; Ewald F; Hofmann BT; Staufer K; Schumacher U; Nashan B; Jücker M
Mol Cancer; 2012 Nov; 11():85. PubMed ID: 23167739
[TBL] [Abstract][Full Text] [Related]
3. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism.
Liu Y; Zhao Y; Guo L
Mol Cell Endocrinol; 2016 Jan; 420():208-16. PubMed ID: 26549689
[TBL] [Abstract][Full Text] [Related]
4. VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway.
Zhangyuan G; Wang F; Zhang H; Jiang R; Tao X; Yu D; Jin K; Yu W; Liu Y; Yin Y; Shen J; Xu Q; Zhang W; Sun B
Oncogene; 2020 Feb; 39(6):1213-1230. PubMed ID: 31605014
[TBL] [Abstract][Full Text] [Related]
5. VLCAD inhibits the proliferation and invasion of hepatocellular cancer cells through regulating PI3K/AKT axis.
Zhu QW; Yu Y; Zhang Y; Wang XH
Clin Transl Oncol; 2022 May; 24(5):864-874. PubMed ID: 35001339
[TBL] [Abstract][Full Text] [Related]
6. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
7. AKT isoforms 1 and 3 regulate basal and epidermal growth factor-stimulated SGHPL-5 trophoblast cell migration in humans.
Haslinger P; Haider S; Sonderegger S; Otten JV; Pollheimer J; Whitley G; Knöfler M
Biol Reprod; 2013 Mar; 88(3):54. PubMed ID: 23303682
[TBL] [Abstract][Full Text] [Related]
8. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
10. The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis.
Luo X; Zheng E; Wei L; Zeng H; Qin H; Zhang X; Liao M; Chen L; Zhao L; Ruan XZ; Yang P; Chen Y
Cell Death Dis; 2021 Mar; 12(4):328. PubMed ID: 33771982
[TBL] [Abstract][Full Text] [Related]
11. AKT activation was not essential for hepatocellular carcinoma cell survival under glucose deprivation.
Zhou J; Tang Y; Xie ZJ; Lu JN; Deng JH; Huang XW; Chuan Hooi S; He M; Lu GD
Anticancer Drugs; 2017 Apr; 28(4):427-435. PubMed ID: 28085697
[TBL] [Abstract][Full Text] [Related]
12. K-Ras(V12) differentially affects the three Akt isoforms in lung and pancreatic carcinoma cells and upregulates E-cadherin and NCAM via Akt3.
Geißert R; Lammert A; Wirth S; Hönig R; Lohfink D; Unger M; Pek D; Schlüter K; Scheftschik T; Smit DJ; Jücker M; Menke A; Giehl K
Cell Commun Signal; 2024 Jan; 22(1):85. PubMed ID: 38291468
[TBL] [Abstract][Full Text] [Related]
13. The role of AKT isoforms in glioblastoma: AKT3 delays tumor progression.
Joy A; Kapoor M; Georges J; Butler L; Chang Y; Li C; Crouch A; Smirnov I; Nakada M; Hepler J; Marty M; Feuerstein BG
J Neurooncol; 2016 Oct; 130(1):43-52. PubMed ID: 27422127
[TBL] [Abstract][Full Text] [Related]
14. Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma.
Zhao C; Wang B; Liu E; Zhang Z
Cell Commun Signal; 2020 Aug; 18(1):131. PubMed ID: 32831114
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg3 and sorafenib combination therapy relieves the hepatocellular carcinomaprogression through regulating the HK2-mediated glycolysis and PI3K/Akt signaling pathway.
Wei Q; Ren Y; Zheng X; Yang S; Lu T; Ji H; Hua H; Shan K
Bioengineered; 2022 May; 13(5):13919-13928. PubMed ID: 35719058
[TBL] [Abstract][Full Text] [Related]
16. Piezoeletric cold atmospheric plasma induces apoptosis and autophagy in human hepatocellular carcinoma cells through blocking glycolysis and AKT/mTOR/HIF-1α pathway.
Wang Y; Mang X; Li D; Chen Y; Cai Z; Tan F
Free Radic Biol Med; 2023 Nov; 208():134-152. PubMed ID: 37543168
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma.
Zhou L; Zhao Y; Pan LC; Wang J; Shi XJ; Du GS; He Q
World J Gastroenterol; 2022 Aug; 28(32):4600-4619. PubMed ID: 36157928
[TBL] [Abstract][Full Text] [Related]
18. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
19. Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells.
Häggblad Sahlberg S; Mortensen AC; Haglöf J; Engskog MK; Arvidsson T; Pettersson C; Glimelius B; Stenerlöw B; Nestor M
Int J Oncol; 2017 Jan; 50(1):5-14. PubMed ID: 27878243
[TBL] [Abstract][Full Text] [Related]
20. Context dependent isoform specific PI3K inhibition confers drug resistance in hepatocellular carcinoma cells.
Narci K; Kahraman DC; Koyas A; Ersahin T; Tuncbag N; Atalay RC
BMC Cancer; 2022 Mar; 22(1):320. PubMed ID: 35331184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
